Brief: Pherecydes Pharma And Bioaster To Collaborate In Treatment Of Bacteremia
11/03/2022 06:12
March 11 (Reuters) - Pherecydes Pharma SA ALPHE.PA :
* PHERECYDES PHARMA AND BIOASTER JOIN FORCES IN TREATMENT OF
BACTEREMIA
* ANNOUNCE IMPLEMENTATION OF RESEARCH COLLABORATION TO USE
PHAGES
TO TREAT BACTEREMIA (BLOOD INFECTIONS) CAUSED BY THE S. AUREUS,
E. COLI AND PSEUDOMONAS AERUGINOSA BACTERIA
Source text for Eikon: ID:nBw9ghz0ca
Further company coverage: ALPHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pherecydes Pharma SA
See all newsBrief: Erytech And Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
Brief: Pherecydes Pharma SA - Pherecydes Pharma And Erytech Pharma Shareholders Approve Merger Between Two Companies To Create Phaxiam Therapeutics
Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
Brief: Erytech: urges shareholders to vote for merger with Pherecydes and dismisses Akkadian's moves
Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes